Filtern
Erscheinungsjahr
Dokumenttyp
- Zeitschriftenartikel (25)
- Vortrag (13)
- Posterpräsentation (6)
Schlagworte
- Deoxynivalenol (3)
- Glucuronidation (3)
- Phase I metabolism (3)
- Cyanotoxin (2)
- Cylindrospermopsin (2)
- ERM (2)
- Food (2)
- Fusarium mycotoxins (2)
- HPLC-MS/MS (2)
- Hydroxylation (2)
- Masked mycotoxins (2)
- Metabolism (2)
- Mycotoxins (2)
- Quantification (2)
- 3,4,4'-trichlorocarbanilide (1)
- Acetyl-DON (1)
- Alpha-zearalenol (1)
- Analytical standards (1)
- Analytik (1)
- Bioaccumulation (1)
- Biosynthesis (1)
- Bran (1)
- Brassicaceae (1)
- Brominated flame retardant (1)
- Caco-2 cells (1)
- Cis-ZEN (1)
- Claviceps purpurea (1)
- Cleanup effectiveness (1)
- Conjugation (1)
- Cyanobacterial toxin (1)
- Cyanotoxine (1)
- Cytochrome P-450 (1)
- Cytochromes (1)
- DON-3-glucoside (1)
- Deoxynivalenol (DON) (1)
- Depletion kinetics (1)
- Detoxification (1)
- Diaporthe toxica (1)
- Dynamic light scattering (1)
- Ergotamine (1)
- Ergotoxine (1)
- Exposure source (1)
- Fermentation (1)
- Field-flow fractionation (1)
- Flour extraction (1)
- Food fermentation (1)
- Food safety (1)
- Germination (1)
- HPLC-FLD (1)
- HRMS (1)
- Harmful algal bloom (1)
- HepaRG cells (1)
- Hepatic metabolism (1)
- Human health (1)
- Human recombinant UGT (1)
- In vitro digestion (1)
- Inter-species comparison (1)
- Isotopic labeled internal standard (1)
- LC-HRMS (1)
- LC-MS/MS (1)
- Lebensmittel (1)
- Liver tissue fractions (1)
- Lupins (1)
- Malting (1)
- Masked mycotoxin (1)
- Mass spectrometry (1)
- Metabolites (1)
- Microbial conversion (1)
- Microsomes (1)
- Modified mycotoxins (1)
- Multi-mycotoxin determination (1)
- Mycotoxin biotransformation (1)
- Mycotoxins and fungal metabolites (1)
- Mykotoxine (1)
- Nivalenol (1)
- Okadaic acid (1)
- Phase II metabolism (1)
- Phomopsin A (1)
- Plant systemic availability (1)
- Quality assurance (1)
- Rapid and validated methods (1)
- Recovery rate (1)
- Referenzmaterial (1)
- Regulations (1)
- Rhizopus and Aspergillus oryzae (1)
- Rye (1)
- SIDA (1)
- Sampling (1)
- Silver nanoparticles (1)
- Small-angle X-ray scattering (1)
- Spin-columns (1)
- Stability (1)
- Stable isotope dilution assay (1)
- Surface water (1)
- Trichothecene (1)
- UPLC-MS/MS (1)
- Uridine-diphosphoglucuronyltransferases (UGT) (1)
- Vegetable plants (1)
- Zearalenone (1)
- Zearalenone sulfate (1)
- Zearalenone-sulfate (1)
- a-zearalenol (1)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (13)
Deoxynivalenol (DON) is one of the most abundant mycotoxins contaminating food and feed worldwide. Upon absorption, the major portion of the toxin is excreted by humans and animal species as glucuronide. However, consistent in vitro data on DON glucuronidation are lacking. In the present study, the metabolism of DON was investigated using liver microsomes from humans and six different animal species. It was shown that all animal and human liver microsomes led to the formation of up to three different mono-O-glucuronides with significant interspecies differences. While the activity of human liver microsomes was low (0.8 to 2.2 pmol·min–1·mg–1), bovine liver and rat liver microsomes conjugated DON with activities of 525 pmol·min–1·mg–1 and 80 pmol·min–1·mg–1, respectively.
Wenn in einem Lebensmittel keine Schimmelpilzgifte nachweisbar sind, muss das nicht bedeuten, dass keine enthalten sind. Prozesse der Lebensmittelverarbeitung, etwa das Mälzen in der Brauerei, führen dazu, dass Glucoside oder Sulfate der Toxine entstehen. Sie sind wenig charakterisiert und analytisch bisher kaum fassbar.
Mycotoxins are natural contaminants produced by a range of fungal species. Their common occurrence in food and feed poses a threat to the health of humans and animals. This threat is caused either by the direct contamination of agricultural commodities or by a "carry-over" of mycotoxins and their metabolites into animal tissues, milk, and eggs after feeding of contaminated hay or corn. As a consequence of their diverse chemical structures and varying physical properties, mycotoxins exhibit a wide range of biological effects. Individual mycotoxins can be genotoxic, mutagenic, carcinogenic, teratogenic, and oestrogenic. To protect consumer health and to reduce economic losses, surveillance and control of mycotoxins in food and feed has become a major objective for producers, regulatory authorities and researchers worldwide. However, the variety of chemical structures makes it impossible to use one single technique for mycotoxin analysis. Hence, a vast number of analytical methods has been developed and validated. The heterogeneity of food matrices combined with the demand for a fast, simultaneous and accurate determination of multiple mycotoxins creates enormous challenges for routine analysis. The most crucial issues will be discussed in this review. These are (1) the collection of representative samples, (2) the performance of classical and emerging analytical methods based on chromatographic or immunochemical techniques, (3) the validation of official methods for enforcement, and (4) the limitations and future prospects of the current methods.
Vergleich von in-vitro-Metabolismusmodellen mit in vivo-Daten am Beispiel der Rotkleeisoflavone
(2010)
The degradation and epimerization of ergot alkaloids (EAs) in rye flour were investigated after baking cookies and subsequently subjecting them to an in vitro digestion model. Different steps of digestion were analyzed using salivary, gastric, and duodenal juices. The degradation and bidirectional conversion of the toxicologically relevant (R)-epimers and the biologically inactive (S)-epimers for seven pairs of EAs were determined by a HPLC method coupled with fluorescence detection. Baking cookies resulted in degradation of EAs (2–30 %) and a shift in the epimeric ratio toward the (S)-epimer for all EAs. The applied digestion model led to a selective toxification of ergotamine and ergosine, two ergotamine-type EAs. The initial percentage of the toxic (R)-epimer in relation to the total toxin content was considerably increased after digestion of cookies. Ergotamine and ergosine increased from 32 to 51 % and 35 to 55 %, respectively. In contrast, EAs of the ergotoxine type (ergocornine, α- and β-ergocryptine, and ergocristine) showed an epimeric shift toward their biologically inactive (S)-epimers. Further experiments indicated that the selective epimerization of ergotamine EAs occurs in the duodenal juice only. These results demonstrate that toxification of EAs in the intestinal tract should be taken into consideration.